CytomX Therapeutics
CTMX
£1.72
Share price
3.96%
Change (1 day)
63.83%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : £53.43 Million
According to CytomX Therapeutics 's latest financial reports the company's total liabilities are £53.43 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CytomX Therapeutics - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | £96.41 M | -50.72% |
| 2023-12-31 | £0.19 B | -31.72% |
| 2022-12-31 | £0.28 B | 13.8% |
| 2021-12-31 | £0.25 B | -6.34% |
| 2020-12-31 | £0.26 B | 21.49% |
| 2019-12-31 | £0.22 B | -13.9% |
| 2018-12-31 | £0.25 B | 5.98% |
| 2017-12-31 | £0.24 B | 148.02% |
| 2016-12-31 | £97.77 M | 103.66% |
| 2015-12-31 | £48 M | -50.7% |
| 2014-12-31 | £97.37 M | 174.74% |
| 2013-12-31 | £35.44 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | £16.82 M | -68.52% | 🇺🇸 USA |